8A-PDHQ
 | |
| Systematic (IUPAC) name | |
|---|---|
|
8a-phenyldecahydroquinoline | |
| Identifiers | |
| CAS Number |
131556-11-1  |
| PubChem | CID 131397 |
| ChemSpider |
116144  |
| Chemical data | |
| Formula | C15H21N |
| Molar mass | 215.3339 g/mol |
| |
| |
| (what is this?) (verify) | |
8a-Phenyldecahydroquinoline (8A-PDHQ) is a high affinity NMDA antagonist developed by a team at Parke Davis in the 1950s.[1] It is a structural analog of Phencyclidine with slightly lower binding affinity than the parent compound. (-)-8a-Phenyldecahydroquinoline has an in vivo potency comparable to that of (+)-MK-801.[2][3]
References
- ↑ US Patent 3035059
- ↑ Chen C, Kozikowski AP, Wood PL, Reynolds IJ, Ball RG, Pang YP (1992). "Synthesis and biological activity of 8a-phenyldecahydroquinolines as probes of PCP's binding conformation. A new PCP-like compound with increased in vivo potency". Journal of Medicinal Chemistry 35 (9): 1634–8. doi:10.1021/jm00087a020. PMID 1315871.
- ↑ Elhallaoui M, Laguerre M, Carpy A, Ouazzani FC (2002). "Molecular modeling of noncompetitive antagonists of the NMDA receptor: proposal of a pharmacophore and a description of the interaction mode". J Mol Model 8 (2): 65–72. doi:10.1007/s00894-001-0067-4. PMID 12032600.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Sunday, October 27, 2013. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.